Illumina (ILMN) Total Non-Current Liabilities (2010 - 2026)
Illumina (ILMN) posted quarterly Total Non-Current Liabilities of $6.4 billion for Q2 2026, up 10.84% year-over-year from $5.7 billion in Q2 2025, and up 2.48% on a QoQ basis from $6.2 billion in Q1 2026.
Illumina (ILMN) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends
Illumina has reported Total Non-Current Liabilities for 17 years, with the latest figure at $6.4 billion in Q2 2026.
- Total Non-Current Liabilities for Q2 2026 came in at $6.4 billion, up 10.84% year-over-year; the trailing twelve-month figure through Jun 2026 was $6.4 billion (up 10.84% YoY), and the FY2025 annual result was $6.3 billion, up 5.37% from the prior year.
- Total Non-Current Liabilities grew to $6.4 billion in Q2 2026, from $6.2 billion in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $14.6 billion in Q3 2022 and troughed at $5.7 billion in Q3 2024.
- A 5-year average of $8.9 billion and a median of $9.4 billion in 2024 frame the typical range for Total Non-Current Liabilities.
- The widest annual swing landed in 2022, when Total Non-Current Liabilities soared 96.4%; it then slumped 48.07% in 2024.
- A 5-year view of Total Non-Current Liabilities shows it stood at $10.6 billion in 2022, then fell by 10.82% to $9.5 billion in 2023, then tumbled by 37.16% to $6.0 billion in 2024, then increased by 5.37% to $6.3 billion in 2025, then grew by 1.23% to $6.4 billion in 2026.
- Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $6.4 billion in Q2 2026, $6.2 billion in Q1 2026, and $6.3 billion in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.92 Bn | 209.86 Bn | 8.34 Bn | 108.64 Bn |
| 2 | Danaher | 140.37 Bn | 136.02 Bn | 3.61 Bn | 85.84 Bn |
| 3 | Idexx Laboratories | 46.17 Bn | 45.97 Bn | 779.09 Mn | 542.10 Mn |
| 4 | Agilent Technologies | 39.76 Bn | 37.96 Bn | 990.00 Mn | 5.45 Bn |
| 5 | Iqvia Holdings | 39.41 Bn | 37.33 Bn | 1.44 Bn | 22.94 Bn |
| 6 | Natera | 38.75 Bn | 37.65 Bn | 696.04 Mn | 737.18 Mn |
| 7 | Illumina | 30.07 Bn | 28.90 Bn | 770.00 Mn | 6.36 Bn |
| 8 | Mettler Toledo International | 28.62 Bn | 28.56 Bn | 650.22 Mn | 3.39 Bn |
| 9 | Quest Diagnostics | 26.15 Bn | 25.53 Bn | 1.03 Bn | 15.88 Bn |
| 10 | Labcorp Holdings | 25.87 Bn | 24.89 Bn | 1.01 Bn | 9.65 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 28, 2026 | 6.36 Bn |
| Mar 29, 2026 | 6.21 Bn |
| Dec 28, 2025 | 6.28 Bn |
| Sep 28, 2025 | 5.84 Bn |
| Jun 29, 2025 | 5.74 Bn |
| Mar 30, 2025 | 5.84 Bn |
| Dec 29, 2024 | 5.96 Bn |
| Sep 29, 2024 | 5.70 Bn |
| Jun 30, 2024 | 5.75 Bn |
| Mar 31, 2024 | 9.40 Bn |
| Dec 31, 2023 | 9.49 Bn |
| Oct 1, 2023 | 9.57 Bn |
| Jul 2, 2023 | 11.07 Bn |
| Apr 2, 2023 | 11.16 Bn |
| Jan 1, 2023 | 11.60 Bn |
| Oct 2, 2022 | 10.64 Bn |
| Jul 3, 2022 | 14.60 Bn |
| Apr 3, 2022 | 14.43 Bn |
| Jan 2, 2022 | 14.30 Bn |
| Oct 3, 2021 | 13.98 Bn |